ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, today announced that it has entered into a ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $144.12, ...

Ethereum, or 1 ETH, traded at $2,352.32 as of 8 a.m. ET. The highest intraday price the cryptocurrency reached in the past ...

In this week's edition of Petri Dish, a Boston cancer biotech is on the hunt for a new CFO, a startup has signed a deal ahead ...

The global lactic acid esters market is anticipated to experience significant growth, with a projected compound annual growth rate (CAGR) of 6.9% from 2017 to 2027. This robust growth is driven by ...

The German veterinary vaccines market is poised for significant growth, projected to achieve a compound annual growth rate ...

Patient advocacy groups are often funded through pharmaceutical companies, but there are currently no regulations governing ...

The price of ethereum, or 1 ETH, traded at $2,455.31, as of 8 a.m. ET. The highest intraday price that ethereum reached in ...

Summit is worth more than $16 billion right now, but where the healthcare stock goes from here will depend heavily on the success of its cancer drug, ivonescimab. In a late-stage trial for advanced ...

It’s the first time, according to the insurer, that this type of model has been used to bring a Humira biosimilar to market, and it yields a much lower cost than both the brand-name version of the ...

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law requiring pharmaceutical companies to negotiate drug prices with the ...

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning ...